Related Experiment Video

Updated: May 31, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice

Kate T Murphy1, Annabel Chee, Ben G Gleeson

  • 1Basic and Clinical Myology Laboratory, Department of Physiology, The University of Melbourne, Victoria, Australia.

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|June 17, 2011
PubMed

Insights

Antibody treatment targeting myostatin prevented muscle wasting and weakness in mice with cancer cachexia. This approach shows promise for treating cancer-related muscle loss and improving patient function.

Area of Science:

  • Biomedical Science
  • Oncology
  • Muscle Physiology

Background:

  • Cancer cachexia is a debilitating condition causing significant muscle wasting and weakness in cancer patients.
  • It contributes to over 20% of cancer-related deaths, highlighting an urgent need for effective treatments.
  • Myostatin is a key regulator of muscle mass, making it a potential therapeutic target.

Purpose of the Study:

  • To investigate the efficacy of antibody-directed myostatin inhibition in preventing muscle atrophy and functional decline in a mouse model of cancer cachexia.
  • To assess the impact of myostatin inhibition on muscle mass, force production, oxidative enzyme activity, and apoptosis in tumor-bearing mice.

Main Methods:

  • Lewis lung carcinoma (LLC) cells were injected into mice to induce cancer cachexia.
  • Tumor-bearing mice were treated with a myostatin inhibitor antibody (PF-354) or saline.
  • Muscle mass, force generation (tibialis anterior and diaphragm), enzyme activity, and apoptosis were measured.

Main Results:

  • LLC injection led to significant muscle atrophy and weakness in tibialis anterior muscles, which was prevented by PF-354 treatment.
  • While diaphragm muscle force decreased in tumor-bearing mice, PF-354 did not improve it.
  • PF-354 treatment significantly increased oxidative enzyme activity and reduced non-myofibrillar/satellite cell apoptosis in limb muscles of tumor-bearing mice.

Conclusions:

  • Antibody-directed myostatin inhibition effectively attenuated skeletal muscle atrophy and loss of muscle force in a murine cancer cachexia model.
  • The treatment's benefits appear to be partly mediated by a reduction in apoptosis.
  • These findings underscore the therapeutic potential of myostatin inhibition for combating cancer cachexia and improving limb muscle function in patients.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...